|
⚲
|
| Keyboard |
| Altiva Management Inc
✚
|
|
|---|---|
| CIK # | 0001772491 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001772491] | |
| 4 | [0001772491] | |
| SC 13D | [0001772491] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Altiva Management Inc | Progenics Pharmaceuticals Inc | [2019-04-05] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Venkataraman Balaji | |
| Altiva Management Inc | |
| Progenics Pharmaceuticals Inc | |
| Velan Capital LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Progenics Pharmaceuticals Inc PGNX
Common Stock, $0.0013 par value
|
2019-09-09 | Buy | 72,023 | $4.99 | 359,395 |
|
Progenics Pharmaceuticals Inc PGNX
Common Stock, $0.0013 par value
|
2019-09-04 | Buy | 243,614 | $4.51 | 1,098,699 |
|
Progenics Pharmaceuticals Inc PGNX
Common Stock, $0.0013 par value
|
2019-09-03 | Buy | 277,424 | $4.39 | 1,217,891 |
|
Progenics Pharmaceuticals Inc PGNX
Common Stock, $0.0013 par value
|
2019-08-26 | Buy | 73,230 | $4.30 | 314,889 |
|
Progenics Pharmaceuticals Inc PGNX
Common Stock, $0.0013 par value
|
2019-08-23 | Buy | 130,826 | $4.31 | 563,860 |